19
Nov
Nov
Soberana-02 COVID-19 vaccine jointly developed by Iran and Cuba will complete clinical trials by mid-June by being administered to 24,000 Iranians.
Tag Archives: mid-June
Soberana-02 COVID-19 vaccine jointly developed by Iran and Cuba will complete clinical trials by mid-June by being administered to 24,000 Iranians.